Whitehawk Therapeutics (WHWK) Share-based Compensation Growth (1y) (2017 - 2026)
Whitehawk Therapeutics (WHWK) Share-based Compensation Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -40.86% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | 30.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.54% |
| Dec 31, 2025 | 28.80% |
| Sep 30, 2025 | 208.96% |
| Jun 30, 2025 | 8.74% |
| Mar 31, 2025 | -53.19% |
| Dec 31, 2024 | -40.41% |
| Sep 30, 2024 | -16.14% |
| Jun 30, 2024 | -7.04% |
| Mar 31, 2024 | 30.99% |
| Dec 31, 2023 | 156.24% |
| Sep 30, 2023 | 10.59% |
| Jun 30, 2023 | 36.64% |
| Mar 31, 2023 | 53.85% |
| Dec 31, 2022 | -469.79% |
| Sep 30, 2022 | 325.46% |
| Jun 30, 2022 | 5,630.77% |
| Mar 31, 2022 | 4,847.22% |
| Dec 31, 2021 | 3,735.90% |
| Sep 30, 2021 | 1,805.88% |
| Jun 30, 2021 | -87.35% |